The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Targeting mechanisms of Pseudomonas aeruginosa pathogenesis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
Stover, C. K., Pham, X. Q., Erwin, A. L., Mizoguchi, S. D., Warrener, P., Hickey, M. J., Brinkman, F. S. L., Hufnagle, W. O., Kowalik, D. J., Lagrou, M., et al. (2000) · Nature · doi:10.1038/35023079 · Cited by 4,573
Ventilator-associated Pneumonia
Chastre, J., & Fagon, J.-Y. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.7.2105078 · Cited by 2,812
Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors
Hentzer, M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg366 · Cited by 1,422
Type IV Pili and Twitching Motility
Mattick, J. S. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.160938 · Cited by 1,255
Quenching quorum-sensing-dependent bacterial infection by an N-acyl homoserine lactonase
Dong, Y.-H., Wang, L.-H., Xu, J.-L., Zhang, H.-B., Zhang, X.-F., & Zhang, L.-H. (2001) · Nature · doi:10.1038/35081101 · Cited by 1,064
Hentzer, M., Riedel, K., Rasmussen, T. B., Heydorn, A., Andersen, J. B., Parsek, M. R., Rice, S. A., Eberl, L., Molin, S., Høiby, N., et al. (2002) · Microbiology · doi:10.1099/00221287-148-1-87 · Cited by 1,050
Iregui, M., Ward, S., Sherman, G., Fraser, V. J., & Kollef, M. H. (2002) · Chest · doi:10.1378/chest.122.1.262 · Cited by 956
Pathogen–Host Interactions in Pseudomonas aeruginosa Pneumonia
Sadikot, R. T., Blackwell, T. S., Christman, J. W., & Prince, A. S. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200408-1044so · Cited by 799
Cell-to-Cell Signaling and Pseudomonas aeruginosa Infections
Van Delden, C., & Iglewski, B. H. (1998) · Emerging Infectious Diseases · doi:10.3201/eid0404.980405 · Cited by 745
P. aeruginosa quorum-sensing systems and virulence
Smith, R. (2003) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(03)00008-0 · Cited by 704
Alginate Overproduction Affects Pseudomonas aeruginosa Biofilm Structure and Function
Hentzer, M., Teitzel, G. M., Balzer, G. J., Heydorn, A., Molin, S., Givskov, M., & Parsek, M. R. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5395-5401.2001 · Cited by 693
The role of pyocyanin in Pseudomonas aeruginosa infection
Lau, G. W., Hassett, D. J., Ran, H., & Kong, F. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.10.002 · Cited by 688
Screening for Quorum-Sensing Inhibitors (QSI) by Use of a Novel Genetic System, the QSI Selector
Rasmussen, T. B., Bjarnsholt, T., Skindersoe, M. E., Hentzer, M., Kristoffersen, P., Köte, M., Nielsen, J., Eberl, L., & Givskov, M. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.5.1799-1814.2005 · Cited by 622
Siderophore-mediated signaling regulates virulence factor production in Pseudomonas aeruginosa
Lamont, I. L., Beare, P. A., Ochsner, U., Vasil, A. I., & Vasil, M. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092016999 · Cited by 584
Human Toll-like receptor 4 recognizes host-specific LPS modifications
Hajjar, A. M., Ernst, R. K., Tsai, J. H., Wilson, C. B., & Miller, S. I. (2002) · Nature Immunology · doi:10.1038/ni777 · Cited by 579
Pyoverdin is essential for virulence of Pseudomonas aeruginosa
Meyer, J. M., Neely, A., Stintzi, A., Georges, C., & Holder, I. A. (1996) · Infection and Immunity · doi:10.1128/iai.64.2.518-523.1996 · Cited by 521
ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury
Finck‐Barbançon, V., Goranson, J., Zhu, L., Sawa, T., Wiener‐Kronish, J. P., Fleiszig, S. M. J., Wu, C., Mende‐Mueller, L., & Frank, D. W. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.4891851.x · Cited by 518
Self-citationRole of Flagella in Pathogenesis of Pseudomonas aeruginosa Pulmonary Infection
Feldman, M., Bryan, R., Rajan, S., Scheffler, L., Brunnert, S., Tang, H., & Prince, A. (1998) · Infection and Immunity · doi:10.1128/iai.66.1.43-51.1998 · Cited by 490
Specific Lipopolysaccharide Found in Cystic Fibrosis Airway Pseudomonas aeruginosa
Ernst, R. K., Yi, E. C., Guo, L., Lim, K. B., Burns, J. L., Hackett, M., & Miller, S. I. (1999) · Science · doi:10.1126/science.286.5444.1561 · Cited by 484
Mathee, K., Ciofu, O., Sternberg, C., Lindum, P. W., Campbell, J. I. A., Jensen, P., Johnsen, A. H., Givskov, M., Ohman, D. E., Søren, M., et al. (1999) · Microbiology · doi:10.1099/13500872-145-6-1349 · Cited by 484
Wozniak, D. J., Wyckoff, T. J. O., Starkey, M., Keyser, R., Azadi, P., O'Toole, G. A., & Parsek, M. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1231792100 · Cited by 466
ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system
Yahr, T. L., Vallis, A. J., Hancock, M. K., Barbieri, J. T., & Frank, D. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13899 · Cited by 464
Roy‐Burman, A., Savel, R. H., Racine, S., Swanson, B. L., Revadigar, N. S., Fujimoto, J., Sawa, T., Frank, D. W., & Wiener‐Kronish, J. P. (2001) · The Journal of Infectious Diseases · doi:10.1086/320737 · Cited by 455
Self-citationWu, H. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh223 · Cited by 446
DiMango, E., Zar, H. J., Bryan, R., & Prince, A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118275 · Cited by 433
Telford, G., Wheeler, D., Williams, P., Tomkins, P. T., Appleby, P., Sewell, H., Stewart, G. S. A. B., Bycroft, B. W., & Pritchard, D. I. (1998) · Infection and Immunity · doi:10.1128/iai.66.1.36-42.1998 · Cited by 423
Antibacterial Agents That Inhibit Lipid A Biosynthesis
Onishi, H. R., Pelak, B. A., Gerckens, L. S., Silver, L. L., Kahan, F. M., Chen, M.-H., Patchett, A. A., Galloway, S. M., Hyland, S. A., Anderson, M. S., et al. (1996) · Science · doi:10.1126/science.274.5289.980 · Cited by 410
Mahenthiralingam, E., Campbell, M. E., & Speert, D. P. (1994) · Infection and Immunity · doi:10.1128/iai.62.2.596-605.1994 · Cited by 408
Azithromycin Inhibits Quorum Sensing in Pseudomonas aeruginosa
Tateda, K., Comte, R., Péchère, J.-C., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1930-1933.2001 · Cited by 401
Wolfgang, M. C., Kulasekara, B. R., Liang, X., Boyd, D., Wu, K., Yang, Q., Miyada, C. G., & Lory, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0832438100 · Cited by 400
Tang, H. B., DiMango, E., Bryan, R., Gambello, M., Iglewski, B. H., Goldberg, J. B., & Prince, A. (1996) · Infection and Immunity · doi:10.1128/iai.64.1.37-43.1996 · Cited by 400
Hauser, A. R., Cobb, E., Bodí, M., Mariscal, D., Vallés, J., Engel, J. N., & Rello, J. (2002) · Critical Care Medicine · doi:10.1097/00003246-200203000-00005 · Cited by 399
He, J., Baldini, R. L., Déziel, E., Saucier, M., Zhang, Q., Liberati, N. T., Lee, D., Urbach, J., Goodman, H. M., & Rahme, L. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0304622101 · Cited by 398
Bactericidal antisense effects of peptide–PNA conjugates
Good, L., Awasthi, S. K., Dryselius, R., Larsson, O., & Nielsen, P. E. (2001) · Nature Biotechnology · doi:10.1038/86753 · Cited by 391
The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU
Sato, H. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg290 · Cited by 390
Pseudomonas aeruginosa Pyocyanin Is Critical for Lung Infection in Mice
Lau, G. W., Ran, H., Kong, F., Hassett, D. J., & Mavrodi, D. (2004) · Infection and Immunity · doi:10.1128/iai.72.7.4275-4278.2004 · Cited by 368
Prevention of hospital-associated pneumonia and ventilator-associated pneumonia
Kollef, M. H. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000128569.09113.fb · Cited by 366
Sawa, T., Yahr, T. L., Ohara, M., Kurahashi, K., Gropper, M. A., Wiener-Kronish, J. P., & Frank, D. W. (1999) · Nature Medicine · doi:10.1038/7391 · Cited by 362
Self-citationVentilator-Associated Pneumonia Due to Pseudomonas Aeruginosa
Brewer, S. C., Wunderink, R. G., Jones, C. B., & Leeper, K. V. (1996) · Chest · doi:10.1378/chest.109.4.1019 · Cited by 361
Smith, R. S., Harris, S. G., Phipps, R., & Iglewski, B. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.4.1132-1139.2002 · Cited by 351
Relative Contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to Virulence in the Lung
Shaver, C. M., & Hauser, A. R. (2004) · Infection and Immunity · doi:10.1128/iai.72.12.6969-6977.2004 · Cited by 350
The type-4 pilus is the major virulence-associated adhesin of Pseudomonas aeruginosa – a review
Hahn, H. P. (1997) · Gene · doi:10.1016/s0378-1119(97)00116-9 · Cited by 334
Pearson, J. P., Feldman, M., Iglewski, B. H., & Prince, A. (2000) · Infection and Immunity · doi:10.1128/iai.68.7.4331-4334.2000 · Cited by 323
Pier, G. B., Grout, M., & Zaidi, T. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.12088 · Cited by 323
Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia
Kurahashi, K., Kajikawa, O., Sawa, T., Ohara, M., Gropper, M. A., Frank, D. W., Martin, T. R., & Wiener-Kronish, J. P. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7124 · Cited by 316
Self-citationGoehring, U.-M., Schmidt, G., Pederson, K. J., Aktories, K., & Barbieri, J. T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36369 · Cited by 303
Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence
Davies, J. C. (2002) · Paediatric Respiratory Reviews · doi:10.1016/s1526-0550(02)00003-3 · Cited by 300
Obritsch, M. D., Fish, D. N., MacLaren, R., & Jung, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4606-4610.2004 · Cited by 288
Pseudomonas aeruginosa biofilms: role of the alginate exopolysaccharide
Boyd, A., & Chakrabarty, A. M. (1995) · Journal of Industrial Microbiology · doi:10.1007/bf01569821 · Cited by 286
Smith, R. S., Fedyk, E. R., Springer, T. A., Mukaida, N., Iglewski, B. H., & Phipps, R. P. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.366 · Cited by 273
Pseudomonas aeruginosa quorum sensing as a potential antimicrobial target
Smith, R. S., & Iglewski, B. H. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320364 · Cited by 271
Impact of Siderophore Production on Pseudomonas aeruginosa Infections in Immunosuppressed Mice
Takase, H., Nitanai, H., Hoshino, K., & Otani, T. (2000) · Infection and Immunity · doi:10.1128/iai.68.4.1834-1839.2000 · Cited by 269
Fu, H., Coburn, J., & Collier, R. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2320 · Cited by 267
Comolli, J. C., Hauser, A. R., Waite, L., Whitchurch, C. B., Mattick, J. S., & Engel, J. N. (1999) · Infection and Immunity · doi:10.1128/iai.67.7.3625-3630.1999 · Cited by 261
Adamo, R., Sokol, S., Soong, G., Gomez, M. I., & Prince, A. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0260oc · Cited by 259
Allen, L., Dockrell, D. H., Pattery, T., Lee, D. G., Cornelis, P., Hellewell, P. G., & Whyte, M. K. B. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3643 · Cited by 257
Reimmann, C., Ginet, N., Michel, L., Keel, C., Michaux, P., Krishnapillai, V., Zala, M., Heurlier, K., Triandafillu, K., Harms, H., et al. (2002) · Microbiology · doi:10.1099/00221287-148-4-923 · Cited by 257
Bacterial cytotoxins: targeting eukaryotic switches
Aktories, K., & Barbieri, J. T. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1150 · Cited by 249
Pseudomonas Pyocyanin Increases Interleukin-8 Expression by Human Airway Epithelial Cells
Denning, G. M., Wollenweber, L. A., Railsback, M. A., Cox, C. D., Stoll, L. L., & Britigan, B. E. (1998) · Infection and Immunity · doi:10.1128/iai.66.12.5777-5784.1998 · Cited by 206
Höffken, G., & Niederman, M. S. (2002) · Chest · doi:10.1378/chest.122.6.2183 · Cited by 205
Whole-Genome Sequence Variation among Multiple Isolates of Pseudomonas aeruginosa
Spencer, D. H., Kas, A., Smith, E. E., Raymond, C. K., Sims, E. H., Hastings, M., Burns, J. L., Kaul, R., & Olson, M. V. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.4.1316-1325.2003 · Cited by 201
Garrity-Ryan, L., Kazmierczak, B., Kowal, R., Comolli, J., Hauser, A., & Engel, J. N. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.7100-7113.2000 · Cited by 191
Allewelt, M., Coleman, F. T., Grout, M., Priebe, G. P., & Pier, G. B. (2000) · Infection and Immunity · doi:10.1128/iai.68.7.3998-4004.2000 · Cited by 190
Wu, H., Song, Z., Givskov, M., Doring, G., Worlitzsch, D., Mathee, K., Rygaard, J., & Høiby, N. (2001) · Microbiology · doi:10.1099/00221287-147-5-1105 · Cited by 189
Inhibition of pulmonary surfactant function by phospholipases
Holm, B. A., Keicher, L., Liu, M. Y., Sokolowski, J., & Enhorning, G. (1991) · Journal of Applied Physiology · doi:10.1152/jappl.1991.71.1.317 · Cited by 187
Phillips, R. M., Six, D. A., Dennis, E. A., & Ghosh, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302472200 · Cited by 185
Effects of Subinhibitory Concentrations of Macrolide Antibiotics on Pseudomonas aeruginosa
Wozniak, D. J., & Keyser, R. (2004) · Chest · doi:10.1378/chest.125.2_suppl.62s · Cited by 183
Structural requirements for TLR4-mediated LPS signalling: a biological role for LPS modifications
Bäckhed, F., Normark, S., Schweda, E. K. H., Oscarson, S., & Richter-Dahlfors, A. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(03)00207-7 · Cited by 177
Quorum sensing: a novel target for anti-infective therapy
Finch, R. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.5.569 · Cited by 176
Smith, R. S., KELLY, R. W., Iglewski, B. H., & Phipps, R. P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2636 · Cited by 175
Pseudomonas aeruginosa Elastase Degrades Surfactant Proteins A and D
Mariencheck, W. I., Alcorn, J. F., Palmer, S. M., & Wright, J. R. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2002-0141oc · Cited by 173
O'Malley, Y. Q., Reszka, K. J., Spitz, D. R., Denning, G. M., & Britigan, B. E. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00025.2004 · Cited by 173
Generation and Characterization of a Protective Monoclonal Antibody to Pseudomonas aeruginosa PcrV
Frank, D. W., Vallis, A. J., Wiener‐Kronish, J. P., Roy‐Burman, A., Spack, E. G., Mullaney, B. P., Megdoud, M., Marks, J. D., Fritz, R. B., & Sawa, T. (2002) · The Journal of Infectious Diseases · doi:10.1086/341069 · Cited by 171
Self-citationGoure, J., Pastor, A., Faudry, E., Chabert, J., Dessen, A., & Attree, I. (2004) · Infection and Immunity · doi:10.1128/iai.72.8.4741-4750.2004 · Cited by 171
Azghani, A. O. (1996) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.15.1.8679217 · Cited by 170
Role of Pseudomonas aeruginosa pili in acute pulmonary infection
Tang, H., Kays, M., & Prince, A. (1995) · Infection and Immunity · doi:10.1128/iai.63.4.1278-1285.1995 · Cited by 168
Role of bacterial proteases in pseudomonal and serratial keratitis
Matsumoto, K. (2004) · Biological Chemistry · doi:10.1515/bc.2004.131 · Cited by 160
Malloy, J. L., Veldhuizen, R. A. W., Thibodeaux, B. A., O’Callaghan, R. J., & Wright, J. R. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00322.2004 · Cited by 156
Pseudomonas aeruginosa Hemolytic Phospholipase C Suppresses Neutrophil Respiratory Burst Activity
Terada, L. S., Johansen, K. A., Nowbar, S., Vasil, A. I., & Vasil, M. L. (1999) · Infection and Immunity · doi:10.1128/iai.67.5.2371-2376.1999 · Cited by 150
Paradoxical cAMP-Induced Lung Endothelial Hyperpermeability Revealed by Pseudomonas aeruginosa ExoY
Sayner, S., Frank, D. W., KING, J. A. C., Chen, H., VandeWaa, J. A., & Stevens, T. (2004) · Circulation Research · doi:10.1161/01.res.0000134922.25721.d9 · Cited by 140
Dulon, S., Leduc, D., Cottrell, G. S., D'Alayer, J., Hansen, K. K., Bunnett, N. W., Hollenberg, M. D., Pidard, D., & Chignard, M. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0274oc · Cited by 139
Pili and lipopolysaccharide of Pseudomonas aeruginosa bind to the glycolipid asialo GM1
Gupta, S. K., Berk, R. S., Masinick, S. A., & Hazlett, L. D. (1994) · Infection and Immunity · doi:10.1128/iai.62.10.4572-4579.1994 · Cited by 137
Yahr, T. L., Barbieri, J. T., & Frank, D. W. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.5.1412-1419.1996 · Cited by 137
Wiener-Kronish, J. P., Sakuma, T., Kudoh, I., Pittet, J., Frank, D. W., Dobbs, L. G., Vasil, M. L., & Matthay, M. A. (1993) · Journal of Applied Physiology · doi:10.1152/jappl.1993.75.4.1661 · Cited by 135
Self-citationCobb, L. M., Mychaleckyj, J. C., Wozniak, D. J., & López-Boado, Y. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5659 · Cited by 129
Alcorn, J. F., & Wright, J. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400796200 · Cited by 126
Pseudomonas aeruginosa lipid A diversity and its recognition by Toll-like receptor 4
Ernst, R. K., Hajjar, A. M., Tsai, J. H., Moskowitz, S. M., Wilson, C. B., & Miller, S. I. (2003) · Journal of Endotoxin Research · doi:10.1177/09680519030090060201 · Cited by 124
Therapeutic Administration of Anti-PcrV F(ab′)2 in Sepsis Associated with Pseudomonas aeruginosa
Shime, N., Sawa, T., Fujimoto, J., Faure, K., Allmond, L. R., Karaca, T. J., Swanson, B. L., Spack, E. G., & Wiener-Kronish, J. P. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5880 · Cited by 123
Self-citationPseudomonas aeruginosa ExoT Acts In Vivo as a GTPase-Activating Protein for RhoA, Rac1, and Cdc42
Kazmierczak, B. I., & Engel, J. N. (2002) · Infection and Immunity · doi:10.1128/iai.70.4.2198-2205.2002 · Cited by 123
Imamura, Y., Yanagihara, K., Mizuta, Y., Seki, M., Ohno, H., Higashiyama, Y., Miyazaki, Y., Tsukamoto, K., Hirakata, Y., Tomono, K., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3457-3461.2004 · Cited by 122
Kudoh, I., Wiener-Kronish, J. P., Hashimoto, S., Pittet, J., & Frank, D. W. (1994) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1994.267.5.l551 · Cited by 121
Self-citationWood, L. G., Fitzgerald, D. A., Lee, A. K., & Garg, M. L. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.1.150 · Cited by 120
In Vivo Rho GTPase-Activating Protein Activity of Pseudomonas aeruginosa Cytotoxin ExoS
Krall, R. F., Sun, J., Pederson, K. J., & Barbieri, J. T. (2002) · Infection and Immunity · doi:10.1128/iai.70.1.360-367.2002 · Cited by 119
Improvement of Alveolar Glutathione and Lung Function but Not Oxidative State in Cystic Fibrosis
Griese, M., Ramakers, J., Krasselt, A. I., Starosta, V., van Koningsbruggen, S., Fischer, R., Ratjen, F. A., Müllinger, B., Huber, R. M., Maier, K., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200308-1104oc · Cited by 112
O’Malley, Y., Reszka, K. J., Rasmussen, G. T., Abdalla, M. Y., Denning, G. M., & Britigan, B. E. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00198.2003 · Cited by 104
Pier, G. B., Boyer, D. M., Preston, M. J., Coleman, F. T., Llosa, N. J., Mueschenborn-Koglin, S., Theilacker, C., Goldenberg, H. B., Uchin, J., Priebe, G. P., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5671 · Cited by 101
König, B., Jaeger, K., Sage, A. E., Vasil, M. L., & König, W. (1996) · Infection and Immunity · doi:10.1128/iai.64.8.3252-3258.1996 · Cited by 101
Lang, A. B., Rüdeberg, A., Schöni, M. H., Que, J. U., Fürer, E., & Schaad, U. B. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000129688.50588.ac · Cited by 99
Different Domains of Pseudomonas aeruginosa Exoenzyme S Activate Distinct TLRs
Epelman, S., Stack, D., Bell, C., Wong, E., Neely, G. G., Krutzik, S. R., Miyake, K., Kubes, P., Zbytnuik, L. D., Ling, L., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.2031 · Cited by 96
Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide (alginate) vaccine
Pier, G. B., DesJardin, D., Grout, M., Garner, C. T., Bennett, S. E., Pekoe, G., Fuller, S., Thornton, M. O., Harkonen, W. S., & Miller, H. (1994) · Infection and Immunity · doi:10.1128/iai.62.9.3972-3979.1994 · Cited by 93
Priebe, G. P., Meluleni, G. J., Coleman, F. T., Goldberg, J. B., & Pier, G. B. (2003) · Infection and Immunity · doi:10.1128/iai.71.3.1453-1461.2003 · Cited by 90
Cantin, A. M., & Woods, D. E. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.4.9807166 · Cited by 87
Role of exotoxin A in inducing severe Pseudomonas aeruginosa infections in mice
Miyazaki, S., Matsumoto, T., Tateda, K., Ohno, A., & Yamaguchi, K. (1995) · Journal of Medical Microbiology · doi:10.1099/00222615-43-3-169 · Cited by 85
Wieland, C. W., Siegmund, B., Senaldi, G., Vasil, M. L., Dinarello, C. A., & Fantuzzi, G. (2002) · Infection and Immunity · doi:10.1128/iai.70.3.1352-1358.2002 · Cited by 85
Faure, K., Fujimoto, J., Shimabukuro, D. W., Ajayi, T., Shime, N., Moriyama, K., Spack, E. G., Wiener-Kronish, J. P., & Sawa, T. (2003) · Journal of Immune Based Therapies and Vaccines · doi:10.1186/1476-8518-1-2 · Cited by 83
Self-citationPankhaniya, R. R., Tamura, M., Allmond, L. R., Moriyama, K., Ajayi, T., Wiener-Kronish, J. P., & Sawa, T. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000145588.79063.07 · Cited by 81
Self-citationRole of the Quorum-sensing System in Experimental Pneumonia due to Pseudomonas aeruginosa in Rats
Lesprit, P., Faurisson, F., Join‐Lambert, O., Roudot‐Thoraval, F., Foglino, M., Vissuzaine, C., & Carbon, C. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200207-736bc · Cited by 80
Kon, Y., Tsukada, H., Hasegawa, T., Igarashi, K., Wada, K., Suzuki, E., Arakawa, M., & Gejyo, F. (1999) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.1999.tb01356.x · Cited by 76
Physiologic, Biochemical, and Imaging Characterization of Acute Lung Injury in Mice
Zhou, Z., KOZLOWSKI, J. K., & Schuster, D. P. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200503-343oc · Cited by 75
Azghani, A. O., Gray, L. D., & Johnson, A. R. (1993) · Infection and Immunity · doi:10.1128/iai.61.6.2681-2686.1993 · Cited by 73
Virulence Factors from Pseudomonas aeruginosa Increase Lung Epithelial Permeability
Azghani, A. O., Miller, E. J., & Peterson, B. T. (2000) · Lung · doi:10.1007/s004080000031 · Cited by 72
Lysophospholipase A activity of Pseudomonas aeruginosa type III secretory toxin ExoU
Tamura, M., Ajayi, T., Allmond, L. R., Moriyama, K., Wiener-Kronish, J. P., & Sawa, T. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.02.050 · Cited by 72
Self-citationMaresso, A. W., Baldwin, M. R., & Barbieri, J. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405707200 · Cited by 71
Sawa, T., Kurahashi, K., Ohara, M., Gropper, M. A., Doshi, V., Larrick, J. W., & Wiener-Kronish, J. P. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3269 · Cited by 63
Self-citationBurgess, D. S. (2005) · Clinical Infectious Diseases · doi:10.1086/426189 · Cited by 62
MASSIVE ALVEOLAR THROMBIN ACTIVATION IN PSEUDOMONAS AERUGINOSA-INDUCED ACUTE LUNG INJURY
Kipnis, É., Guery, B. P., Tournoys, A., et al. (2004) · Shock · doi:10.1097/00024382-200405000-00008 · Cited by 57
Leidal, K. G., Munson, K. L., & Denning, G. M. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.25.2.4273 · Cited by 50
Döring, G., Pfeiffer, C., Weber, U., Mohr-Pennert, A., & Dorner, F. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.4.7697276 · Cited by 49
Alveolar Response toPseudomonas aeruginosa: Role of the Type III Secretion System
Ader, F., Berre, R. L., Faure, K., Gosset, P., Épaulard, O., Toussaint, B., Polack, B., Nowak, E., Viget, N. B., Kipnis, É., et al. (2005) · Infection and Immunity · doi:10.1128/iai.73.7.4263-4271.2005 · Cited by 46
Azghani, A. O., Bedinghaus, T., & Klein, R. A. (2000) · PubMed · doi:10.1007/s004080000021 · Cited by 42
Schultz, M. J., Speelman, P., Zaat, S. A. J., Hack, C. E., van Deventer, S. J. H., & van der Poll, T. (2000) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2000.tb01527.x · Cited by 41
Matsumoto, T., Tateda, K., Furuya, N., Miyazaki, S., Ohno, A., Ishii, Y., Hirakata, Y., & Yamaguchi, K. (1998) · Journal of Medical Microbiology · doi:10.1099/00222615-47-4-303 · Cited by 41
Woods, D. E., Cantin, A. M., Cooley, J., Kenney, D. M., & Remold‐O’Donnell, E. (2004) · Pediatric Pulmonology · doi:10.1002/ppul.20167 · Cited by 40
Impairment of host defence by exotoxin A in Pseudomonas aeruginosa pneumonia in mice
Schultz, M. J., Rijneveld, A. W., Florquin, S., Speelman, P., van Deventer, S. J. H., & van der Poll, T. (2001) · Journal of Medical Microbiology · doi:10.1099/0022-1317-50-9-822 · Cited by 39
Thioredoxin liquefies and decreases the viscoelasticity of cystic fibrosis sputum
Rancourt, R. C., Tai, S., King, M., Heltshe, S. L., Penvari, C., Accurso, F. J., & White, C. W. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00352.2003 · Cited by 32
Cachia, P. J., Kao, D. J., & Hodges, R. S. (2004) · Journal of Molecular Recognition · doi:10.1002/jmr.682 · Cited by 23
Effect of Passive Immunotherapy on Murine Gut-Derived Sepsis Caused by Pseudomonas Aeruginosa
Matsumoto, T., Furuya, N., Tateda, K., Miyazaki, S., Ohno, A., Ishii, Y., Hirakata, Y., & Yamaguchi, K. (1999) · Journal of Medical Microbiology · doi:10.1099/00222615-48-8-765 · Cited by 18
Sawa, T., & Wiener-Kronish, J. P. (2004) · Anesthesiology Clinics of North America · doi:10.1016/j.atc.2004.05.002 · Cited by 17
Self-citation
Cited by
Pseudomonas aeruginosa : new insights into pathogenesis and host defenses
Gellatly, S. L., & Hancock, R. E. W. (2013) · Pathogens and Disease · doi:10.1111/2049-632x.12033 · Cited by 1,295
“Like flagella, pili are targets of antipseudomonal therapy, including immunization; however, these efforts are hampered by the antigenic variability of pili across P. aeruginosa strains (Kipnis et al., 2006).”
BackgroundInfluentialThe Epidemiology, Pathogenesis and Treatment of Pseudomonas aeruginosa Infections
Driscoll, J. A., Brody, S. L., & Kollef, M. H. (2007) · Drugs · doi:10.2165/00003495-200767030-00003 · Cited by 884
Pseudomonas aeruginosa: An Audacious Pathogen with an Adaptable Arsenal of Virulence Factors
Jurado-Martín, I., Sainz-Mejías, M., & McClean, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063128 · Cited by 698
Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium
Mesaros, N., Nordmann, P., Plésiat, P., Roussel-Delvallez, M., Van Eldere, J., Glupczynski, Y., Van Laethem, Y., Jacobs, F., Lebecque, P., Malfroot, A., et al. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01681.x · Cited by 585
World Health Organization Report: Current Crisis of Antibiotic Resistance
Talebi Bezmin Abadi, A., Rizvanov, A. A., Haertlé, T., & Blatt, N. L. (2019) · BioNanoScience · doi:10.1007/s12668-019-00658-4 · Cited by 465
Metadata
- Authors
- Kipnis, E., Sawa, T., & Wiener-Kronish, J.
- Venue
- Médecine et Maladies Infectieuses
- Publisher
- Elsevier BV
- Published
- 2006-02
- Volume
- 36
- Issue
- 2
- Pages
- 78-91
- ISSN
- 0399-077X (ISSN-L)
- OpenAlex
- W2169675452
- Cited by
- 353
- References
- 129
- FWCI
- 6.51
- Type
- journal article
- Language
- fr
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.